Psychedelic Use Linked to 20% Decreased Hypertension Risk, Study Finds

Psychedelic Use Linked to 20% Decreased Hypertension Risk, Study Finds

,
Psychedelic use may help to decrease the risk of hypertension, according to new research.
psychedelic mushrooms

New Study Finds Possible Mechanism for Psilocybin’s Anti-Depressive Effects

,
Scientists are closer to unraveling the mystery behind the psilocybin effects and its ability to offer anti-depressive benefits.
MAPS Founder Rick Doblin Talks MDMA Research for PTSD With Actress Mayim Bialik

MAPS Founder Rick Doblin Discusses MDMA Research for PTSD With Actress Mayim Bialik

,
Rick Doblin, the founder of MAPS, joined actress Mayim Bialik's podcast Breakdown to discuss MDMA and PTSD research.
Mushroom Conference

University of Wisconsin Opens Country’s First Master’s in Psychedelic Medicine

,
The University of Wisconsin is the first in the U.S. to offer a master's degree in development of psychedelic medicine.
Big Pharma Giant Merck Partners With Psychedelic Research Company NovaMind

Big Pharma Giant Merck Partners With Psychedelic Research Company Novamind

Pharmaceutical giant Merck is partnering with psychedelic research company Novamind to test a possible therapy for treatment-resistant depression.
Women Are More Likely to Use Psychedelics Than Men

Survey: Women Use Psychedelics More Often Than Men

,
A new survey finds women are more likely to self-treat with psychedelics than men, particularly for issues including depression and trauma.
These 24 Psychedelic Patents Are Paving the Way for Medicine 2.0

These 24 Psychedelic Patents Are Paving the Way for Medicine 2.0

,
Patents of psychedelic substances are paving the way for new research and treatment options for a variety of diseases.
Establishing the Ethical Imperative in Psychedelic Medicine

Researchers to Hone In On Most Therapeutic Doses of LSD

New research is looking into the optimal dose of LSD to further enhance the therapeutic benefits of the psychedelic.
Awakn Life Sciences Psychedelics

U.K. Psychedelic R&D Company Investigates MDMA, Ketamine for Addiction

Awakn Life Sciences is looking at psychedelics for addiction, namely MDMA and ketamine for alcohol use disorder.
Are the Subjective Effects of Psychedelics Necessary for Therapy?

Are the Subjective Effects of Psychedelics Necessary for Therapy?

Are the subjective effects - that is, the psychedelic trip itself - fundamental for therapeutic outcomes? New research explores.